Exact Sciences Corp - Company Profile
Powered by
All the data and insights you need on Exact Sciences Corp in one report.
- Save hours of research time and resources with
our up-to-date Exact Sciences Corp Strategy Report
- Understand Exact Sciences Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the development of tests for various types of cancers. The company’s flagship product, Cologuard test is a US FDA-approved non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It uses a multi-target approach to detect DNA and hemoglobin biomarkers is related to colorectal cancer. The company also offers Oncotype DX gene expression tests for prostate, breast, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect test, a liquid-based test designed for advanced stage prostate cancer. It operates manufacturing and laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.
Exact Sciences Corp premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Cologuard Test - Non-Invasive Stool-Based DNA (sDNA) Screening Test | Cologuard |
Oncotype DX Gene Expression Tests - for Breast, Prostate and Colon Cancers | LBgard |
Oncotype DX AR-V7 Nucleus Detect Test - for Advanced Stage Prostate Cancer | |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Litigation | In November, the company filed a lawsuit against Geneoscopy, Inc. in the United States District Court for the District of Delaware to stop Geneoscopy from making, using, selling, or offering for sale of Geneoscopy’s ColoSense product. |
2023 | Contracts/Agreements | In September, the company entered into an agreement to acquire Resolution Bioscience from Agilent Technologies, Inc. |
2023 | Contracts/Agreements | In August, the company entered into a multi-year, co-exclusive agreement with Watchmaker Genomics to develop and commercialize the breakthrough DNA methylation analysis technology, TET-assisted pyridine borane sequencing (TAPS). |
Competitor Comparison
Key Parameters | Exact Sciences Corp | Natera Inc | Lineage Cell Therapeutics Inc | StageZero Life Sciences Ltd | Epigenomics AG |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | Canada | Germany |
City | Madison | Austin | Carlsbad | Richmond Hill | Berlin |
State/Province | Wisconsin | Texas | California | Ontario | Baden-Wurttemberg |
No. of Employees | 6,300 | 2,958 | 78 | 40 | 18 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Kevin T. Conroy | President; Chairman; Chief Executive Officer | Executive Board | 2014 | 56 |
Jeffrey T. Elliott | Chief Financial Officer; Chief Operating Officer; Executive Vice President | Senior Management | 2021 | 44 |
Gary Frings | Chief Information Officer | Senior Management | 2015 | - |
Scott Coward | Chief Legal Officer; Secretary; Executive Vice President | Senior Management | 2018 | 57 |
Graham P. Lidgard, Ph.D. | Chief Science Officer | Senior Management | 2009 | 71 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward